Cutting-edge approaches to trial and study design, technology, sourcing, data disclosure and medical communications.

Clinical Trial Vendor Oversight and Governance - WHITEPAPER

ArticleImage

Download the exclusive whitepaper

Outsourcing of clinical trials is undertaken by pharmaceutical companies for a number of reasons including reduction of costs of conducting clinical trials, reducing wastage by engaging a vendor with manpower and expertise in the area of interest for the sponsor, and achieving reduced cycle times of introducing a new product in the market. While these reasons form the basis of outsourcing, the sponsor treads a thin line distinguishing between micromanaging each and every step and effective oversight in the implementation of the clinical trial.

This whitepaper explores:

  • Vector selection: procurement strategies and contract design

  • Regulatory requirements with ICH GCP guidelines

  • Vendor responsibilities for data sharing with the sponsors

  • Quality agreements and monitoring

  • Risk minimization

  • Overseeing technology vendors


To download simply log in or register for an Informa Connect account, which will give you access to all our exclusive premium content.

Have any questions or interested in sponsoring future content? Email andrew.burrows@informa.com.

ABOUT THE AUTHOR: Poonam Balani has a PhD in biomedical sciences from the University of Muenster, Germany. She has 14 years of experience in medical and academic writing and has worked as a researcher at the University of Tennessee Health Science Center, USA and the Institute for Bioengineering and Nanotechnology, Singapore.

Log in or create an Informa Connect account to access this content

Creating an account also means you'll get special access to article updates and exclusive industry content.